Cas no 908591-25-3 (N-Methyl-N-(2-isopropyl-4-thiazolyl)methyl)amine, Hydrochloride Salt)
N-Methyl-N-(2-isopropyl-4-thiazolyl)methyl)amine, Hydrochloride Salt Chemical and Physical Properties
Names and Identifiers
-
- 1-(2-Isopropylthiazol-4-yl)-N-methylmethanamine hydrochloride
- N-Methyl-N-[(2-isopropyl]-4-thiazolyl)methyl)amine, Hydrochloride Salt
- 2-Isopropyl-4-[(N-methylamino)methyl]thiazole hydrochloride
- N-methyl-1-(2-propan-2-yl-1,3-thiazol-4-yl)methanamine,hydrochloride
- 2-Isopropyl-4(((N-methyl)amino)methyl)thiazole HCl
- 1-(2-ISOPROPYLTHIAZOL-4-YL)-N-METHYLMETHANAMINE HCL
- 2-Isopropyl-4(((N-methyl)amino)methyl)thiazole hydrochloride
- N-methyl-1-(2-propan-2-yl-1,3-thiazol-4-yl)methanamine Hydrochloride
- R875
- AX8076123
- ST2414961
- 4-Thiazolemethanamine, N-methyl-2-(1-methylethyl)-, monohydrochloride (9CI)
- N-methyl-1-(2-propan-2-yl-1,3-thiazol-4-yl)methanamine;hydrochloride
- DTXSID70469589
- N-Methyl-1-[2-(propan-2-yl)-1,3-thiazol-4-yl]methanamine--hydrogen chloride (1/1)
- 2-Isopropyl-4-[(N-methylamino)methyl]thiazole hydrochloride, AldrichCPR
- N-Methyl-N-[(2-isopropyl]-4-thiazolyl)methyl)amine Hydrochloride
- MFCD07369525
- AKOS015915056
- SCHEMBL6090064
- 908591-25-3
- C8H15ClN2S
- DS-18351
- AC-8766
- [(2-ISOPROPYL-1,3-THIAZOL-4-YL)METHYL](METHYL)AMINE HYDROCHLORIDE
- 1-(2-Isopropylthiazol-4-yl)-N-methylmethanaminehydrochloride
- CS-0188468
- N-Methyl-N-(2-isopropyl-4-thiazolyl)methyl)amine, Hydrochloride Salt
-
- MDL: MFCD07369525
- Inchi: 1S/C8H14N2S.ClH/c1-6(2)8-10-7(4-9-3)5-11-8;/h5-6,9H,4H2,1-3H3;1H
- InChI Key: MZHCXYATKCSZHX-UHFFFAOYSA-N
- SMILES: Cl.N1C(CNC)=CSC=1C(C)C
Computed Properties
- Exact Mass: 206.06400
- Monoisotopic Mass: 206.0644474g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 12
- Rotatable Bond Count: 3
- Complexity: 117
- Covalently-Bonded Unit Count: 2
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 53.2
Experimental Properties
- Density: 1.1±0.1 g/cm3
- Melting Point: 62-65°C
- Boiling Point: 389.8±42.0 °C at 760 mmHg
- Flash Point: 189.5±27.9 °C
- PSA: 53.16000
- LogP: 3.17880
- Vapor Pressure: 0.0±0.9 mmHg at 25°C
N-Methyl-N-(2-isopropyl-4-thiazolyl)methyl)amine, Hydrochloride Salt Security Information
- Signal Word:Warning
- Hazard Statement: H302-H315-H319-H335
- Warning Statement: P261-P305+P351+P338
- Safety Instruction: H303+H313+H333
- Storage Condition:Sealed in dry,Room Temperature
N-Methyl-N-(2-isopropyl-4-thiazolyl)methyl)amine, Hydrochloride Salt Customs Data
- HS CODE:2934100090
- Customs Data:
China Customs Code:
2934100090Overview:
2934100090. Compounds that structurally contain a non fused thiazole ring(Whether hydrogenated or not). VAT:17.0%. Tax refund rate:9.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to
Summary:
2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0%
N-Methyl-N-(2-isopropyl-4-thiazolyl)methyl)amine, Hydrochloride Salt Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | I304952-250mg |
N-Methyl-N-(2-isopropyl-4-thiazolyl)methyl)amine, Hydrochloride Salt |
908591-25-3 | ≥95% | 250mg |
¥95.90 | 2023-09-02 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | I304952-5g |
N-Methyl-N-(2-isopropyl-4-thiazolyl)methyl)amine, Hydrochloride Salt |
908591-25-3 | ≥95% | 5g |
¥772.90 | 2023-09-02 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | I304952-100mg |
N-Methyl-N-(2-isopropyl-4-thiazolyl)methyl)amine, Hydrochloride Salt |
908591-25-3 | ≥95% | 100mg |
¥64.90 | 2023-09-02 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | I304952-25g |
N-Methyl-N-(2-isopropyl-4-thiazolyl)methyl)amine, Hydrochloride Salt |
908591-25-3 | ≥95% | 25g |
¥2277.90 | 2023-09-02 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | I304952-1g |
N-Methyl-N-(2-isopropyl-4-thiazolyl)methyl)amine, Hydrochloride Salt |
908591-25-3 | ≥95% | 1g |
¥221.90 | 2023-09-02 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | I304952-100g |
1-(2-Isopropylthiazol-4-yl)-N-methylmethanamine hydrochloride |
908591-25-3 | ≥95% | 100g |
¥7,879.00 | 2021-05-25 | |
| Alichem | A059006218-5g |
1-(2-Isopropylthiazol-4-yl)-N-methylmethanamine hydrochloride |
908591-25-3 | 95% | 5g |
$338.99 | 2023-08-31 | |
| Alichem | A059006218-10g |
1-(2-Isopropylthiazol-4-yl)-N-methylmethanamine hydrochloride |
908591-25-3 | 95% | 10g |
$456.50 | 2023-08-31 | |
| Alichem | A059006218-25g |
1-(2-Isopropylthiazol-4-yl)-N-methylmethanamine hydrochloride |
908591-25-3 | 95% | 25g |
$960.99 | 2023-08-31 | |
| Fluorochem | 220379-1g |
1-(2-Isopropylthiazol-4-yl)-N-methylmethanamine hydrochloride |
908591-25-3 | 95% | 1g |
£20.00 | 2022-03-01 |
N-Methyl-N-(2-isopropyl-4-thiazolyl)methyl)amine, Hydrochloride Salt Related Literature
-
Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
-
Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
-
Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
Additional information on N-Methyl-N-(2-isopropyl-4-thiazolyl)methyl)amine, Hydrochloride Salt
Introduction to N-Methyl-N-(2-isopropyl-4-thiazolyl)methyl)amine, Hydrochloride Salt (CAS No. 908591-25-3)
N-Methyl-N-(2-isopropyl-4-thiazolyl)methyl)amine, Hydrochloride Salt, identified by its CAS number 908591-25-3, is a compound of significant interest in the field of pharmaceutical chemistry and biochemistry. This compound belongs to the class of thiazole derivatives, which have been extensively studied due to their diverse biological activities and potential therapeutic applications. The hydrochloride salt form of this molecule enhances its solubility in aqueous solutions, making it more suitable for various biochemical assays and pharmaceutical formulations.
The molecular structure of N-Methyl-N-(2-isopropyl-4-thiazolyl)methyl)amine, Hydrochloride Salt consists of a thiazole ring substituted with an isopropyl group at the 2-position and a methylamine moiety at the 4-position. The presence of the hydrochloride salt indicates that the free base form of the compound has been treated with hydrochloric acid to form a stable salt. This modification not only improves the compound's stability but also its pharmacokinetic properties, which are crucial for drug development.
Recent research in the field of medicinal chemistry has highlighted the importance of thiazole derivatives in the development of new drugs. Thiazole compounds are known for their antimicrobial, anti-inflammatory, and anticancer properties. The specific substitution pattern in N-Methyl-N-(2-isopropyl-4-thiazolyl)methyl)amine, Hydrochloride Salt may contribute to its unique biological activity profile. Studies have shown that thiazole derivatives can interact with various biological targets, including enzymes and receptors, leading to therapeutic effects.
In particular, the isopropyl group at the 2-position of the thiazole ring may enhance the compound's ability to bind to biological targets by increasing its lipophilicity. This property is often desirable in drug design, as it can improve membrane permeability and thus oral bioavailability. Additionally, the methylamine moiety at the 4-position may contribute to hydrogen bonding interactions, further stabilizing the compound's binding affinity to its target proteins.
The hydrochloride salt form of this compound also offers advantages in terms of formulation and storage. Salts generally have better solubility compared to their free base forms, which is beneficial for preparing solutions or suspensions for administration. Moreover, salts are often more stable under various storage conditions, reducing degradation over time. These properties make N-Methyl-N-(2-isopropyl-4-thiazolyl)methyl)amine, Hydrochloride Salt a promising candidate for further investigation in drug development.
Current research efforts are focused on understanding the mechanisms of action of thiazole derivatives and optimizing their pharmacological properties. Computational modeling and high-throughput screening techniques are being employed to identify new analogs with improved efficacy and reduced side effects. The structure-activity relationships (SARs) of compounds like N-Methyl-N-(2-isopropyl-4-thiazolyl)methyl)amine, Hydrochloride Salt are being carefully analyzed to guide future synthetic efforts.
One area of particular interest is the potential application of this compound in treating neurological disorders. Thiazole derivatives have shown promise in preclinical studies as modulators of neurotransmitter systems. The unique structural features of N-Methyl-N-(2-isopropyl-4-thiazolyl)methyl)amine, Hydrochloride Salt may allow it to interact with specific receptors or enzymes involved in neurodegenerative diseases such as Alzheimer's and Parkinson's. Further studies are needed to explore these possibilities and validate their clinical relevance.
Another emerging field where this compound may find utility is in anti-inflammatory therapies. Chronic inflammation is a hallmark of many diseases, including autoimmune disorders and metabolic syndromes. Thiazole derivatives have been reported to inhibit inflammatory pathways by modulating key signaling molecules such as NF-κB and MAP kinases. The potential anti-inflammatory activity of N-Methyl-N-(2-isopropyl-4-thiazolyl)methyl)amine, Hydrochloride Salt warrants further investigation through in vitro and in vivo models.
In conclusion, N-Methyl-N-(2-isopropyl-4-thiazolyl)methyl)amine, Hydrochloride Salt (CAS No. 908591-25-3) represents a promising lead compound for pharmaceutical research due to its unique structural features and potential biological activities. The combination of computational studies and experimental validation will be essential in elucidating its mechanism of action and exploring its therapeutic potential. As our understanding of thiazole derivatives continues to grow, compounds like this one are likely to play a significant role in the development of novel treatments for various diseases.
908591-25-3 (N-Methyl-N-(2-isopropyl-4-thiazolyl)methyl)amine, Hydrochloride Salt) Related Products
- 933707-20-1((2-Ethyl-1,3-thiazol-4-yl)methylamine dihydrochloride Hydrate)
- 1262771-25-4((2-Isopropylthiazol-4-yl)methanamine hydrochloride)
- 903131-67-9(1-[2-(propan-2-yl)-1,3-thiazol-4-yl]methanamine)
- 1171981-10-4((2-Isopropylthiazol-4-yl)methanamine dihydrochloride)
- 154212-60-9(2-Isopropyl-4-(methylaminomethyl)thiazole)
- 165315-63-9(N-cyclopropyl-N-[(2-isopropyl-4-thiazolyl)methyl]amine)
- 937656-81-0((2-tert-butyl-1,3-thiazol-4-yl)methanamine)
- 1246818-86-9(N-Methyl-N-(2-isopropyl-1,1,1,3,3,3-d6-4-thiazolyl)methyl)amine, Hydrochloride Salt)
- 1083299-53-9((2-Cyclopropyl-1,3-thiazol-4-yl)methanamine)
- 1185167-55-8(methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})amine dihydrochloride)